The EDC is live today — see what ships now
All studies
NCT00869817From ClinicalTrials.govRecruiting

Dominantly Inherited Alzheimer Network (DIAN)

  • Alzheimer's Disease

At a glance

Phase
Phase not stated
Study type
Observational
Sponsor
Washington University School of Medicine
Enrolment target
700
Started
January 2009
Main results due
September 2026
Study sites
26
Registry updated
25 September 2026

Can you take part?

  • Aged 18 years and over.
  • Open to any sex.
  • Healthy volunteers can take part.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

* Written informed consent obtained from participant and collateral source prior to any study-related procedures.
* Aged 18 (inclusive) or older and the child of an affected individual (clinically or by testing) in a pedigree with a known mutation for ADAD.
* Cognitively normal to very mild or mild cognitive impairment (CDR score range 0-1.0). Primary enrollment will focus on the recruitment of asymptomatic adult children who are more than 15 years younger than the estimated age of symptom onset. Enrollment of new participants with moderate cognitive impairment is allowed with the prior approval of the DIAN Coordinating Center.
* Has two persons who are not their full-blooded siblings who can serve as collateral sources for the study.
* Fluent in a language approved by the DIAN Coordinating Center at about the 6th grade level (international equivalent) or above.

Exclusion Criteria:

* Under age 18
* Medical or psychiatric illness that would interfere in completing initial and follow-up visits
* Requires nursing home level care
* Has no one who can serve as a study informant

What this study is about

In the sponsor’s own words, from the registry.

The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.

Study sites(26)

  • Mayo Clinic Jacksonville

    Jacksonville, Florida, United States

    Recruiting

  • Indiana University-Indiana Alzheimer Disease Center

    Indianapolis, Indiana, United States

    Recruiting

  • Brigham and Women's Hospital

    Boston, Massachusetts, United States

    Recruiting

  • Washington University in St. Louis School of Medicine

    St Louis, Missouri, United States

    Recruiting

  • Columbia University

    New York, New York, United States

    Suspended

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

    Recruiting

  • Butler Hospital

    Providence, Rhode Island, United States

    Recruiting

  • University of Washington

    Seattle, Washington, United States

    Recruiting

  • Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI)

    Salta, Salta Province, Argentina

    Recruiting

  • Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia" (FLENI) Instituto de Investigaciones Neurológicas Raúl Correa

    Buenos Aires, Argentina

    Recruiting

  • Neuroscience Research Australia

    Sydney, New South Wales, Australia

    Recruiting

  • Mental Health Research Institute, University of Melbourne

    Melbourne, Victoria, Australia

    Suspended

  • Sir James McCusker Alzheimer's Disease Research Unit, Edith Cowan University

    Perth, Western Australia, Australia

    Recruiting

  • Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo

    São Paulo, São Paulo, Brazil

    Recruiting

  • McGill University Research Centre for Studies in Aging

    Verdun, Quebec, Canada

    Not yet recruiting

  • Grupo Neurociencias de Antioquia

    Medellín, Colombia, Colombia

    Recruiting

  • German Center for Neurodegenerative Diseases (DZNE) Munich, and University Hospital Ludwig-Maximilians-Universitat (LMU) Munich

    Munich, Germany

    Recruiting

  • German Center for Neurodegenerative Diseases (DZNE) Tübingen and Hertie-Institute for Clinical Brain Research, University of Tübingen

    Tübingen, Germany

    Recruiting

  • Niigata University

    Niigata, Japan

    Recruiting

  • Osaka City University

    Osaka, Japan

    Suspended

  • Tokyo University

    Tokyo, Japan

    Recruiting

  • Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suarez"

    Mexico City, Mexico City, Mexico

    Recruiting

  • Amsterdam UMC

    Amsterdam, Netherlands

    Recruiting

  • Asan Medical Center

    Seoul, Songpa-Gu, South Korea

    Recruiting

  • Hospital Clinic Barcelona

    Barcelona, Catalonia, Spain

    Suspended

  • Institute of Neurology, Queen Square

    London, United Kingdom

    Recruiting

Showing 26 of 26 sites. 21 of the 26 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT00869817. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
Dominantly Inherited Alzheimer Network (DIAN) | Trialion